rediff.com
e.g. Tata motors, Reliance MF, 500570
Natco Pharma Ltd. - Research Center
524816 NATCOPHARM Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Half yearly results in brief
(Rs crore)
Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21 Sep ' 20
Sales 1,978.80 1,156.80 1,043.60 724.20 1,011.10
Operating profit 946.00 449.50 50.00 163.00 263.00
Interest 6.20 4.40 8.30 5.00 6.00
Gross profit 979.10 494.50 83.70 210.60 304.10
EPS (Rs) 42.77 18.94 0.56 7.06 10.86
Half yearly  results in details
Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21 Sep ' 20
Other income 39.30 49.40 42.00 52.60 47.10
Stock adjustment 39.50 - 62.80 -68.30 9.70
Raw material 302.70 196.20 293.70 225.50 208.00
Power and fuel - - - - -
Employee expenses 226.00 236.50 210.20 199.90 194.80
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 464.60 274.60 426.90 204.10 335.60
Provisions made - - - - -
Depreciation 79.90 75.20 71.10 67.30 56.00
Taxation 133.70 73.60 2.30 14.50 50.50
Net profit / loss 765.50 345.70 10.30 128.80 197.60
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 35.80 36.50 36.50 36.50 36.40
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 47.81 38.86 4.79 22.51 26.01
GPM (%) 48.52 41.00 7.71 27.11 28.74
NPM (%) 37.93 28.66 0.95 16.58 18.67
Close
Add Natco Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Natco Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close